(Q39129968)

English

Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.

scientific article published on 5 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

based on heuristic

inferred from title

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Chia Wen Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

5 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Journal of Drug Targeting

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

776-786

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Nanocarriers' entry into the cell: relevance to drug delivery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

A photochemical approach for controlled drug release in targeted drug delivery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Treatment-related protein biomarker expression differs between primary and recurrent ovarian carcinomas

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Phosphatase and tensin homolog expression related to cetuximab effects in colorectal cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Development and optimization of nanosomal formulations for siRNA delivery to the liver

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

RNA-based therapeutics: current progress and future prospects.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

The Caenorhabditis elegans RDE-10/RDE-11 complex regulates RNAi by promoting secondary siRNA amplification

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Anti-angiogenesis therapy in cancer: current challenges and future perspectives

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Current progress of siRNA/shRNA therapeutics in clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Membrane transporters in drug development

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Nanotechnology: intelligent design to treat complex disease

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Nuclear export of proteins and drug resistance in cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Uptake of FITC-chitosan nanoparticles by A549 cells.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Endocytic mechanisms for targeted drug delivery

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

pH-Responsive copolymer assemblies for controlled release of doxorubicin

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.811511

21 January 2018

Identifiers

10.3109/1061186X.2013.811511

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23829387%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39129968&oldid=1541751744"